Literature DB >> 23768491

Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells.

Marina Lusic1, Bruna Marini, Hashim Ali, Bojana Lucic, Roberto Luzzati, Mauro Giacca.   

Abstract

Nuclear bodies (NBs), characterized by the presence of the promyelocytic leukemia (PML) protein, are important components of the nuclear architecture, contributing to genetic and epigenetic control of gene expression. In investigating the mechanisms mediating HIV-1 latency, we determined that silenced but transcriptionally competent HIV-1 proviruses reside in close proximity to PML NBs and that this association inhibits HIV-1 gene expression. PML binds to the latent HIV-1 promoter, which coincides with transcriptionally inactive facultative heterochromatic marks, notably H3K9me2, at the viral genome. PML degradation and NB disruption result in strong activation of viral transcription as well as release of G9a, the major methyltransferase responsible for H3K9me2, and loss of facultative heterochromatin marks from the proviral DNA. Additionally, HIV-1 transcriptional activation requires proviral displacement from PML NBs by active nuclear actin polymerization. Thus, nuclear topology and active gene movement mediate HIV-1 transcriptional regulation and have implications for controlling HIV-1 latency and eradication.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23768491     DOI: 10.1016/j.chom.2013.05.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  45 in total

1.  Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Authors:  Lara Manganaro; Lars Pache; Tobias Herrmann; John Marlett; Young Hwang; Jeffrey Murry; Lisa Miorin; Adrian T Ting; Renate König; Adolfo García-Sastre; Frederic D Bushman; Sumit K Chanda; John A T Young; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

Review 2.  Underlying mechanisms of HIV-1 latency.

Authors:  Bizhan Romani; Elham Allahbakhshi
Journal:  Virus Genes       Date:  2017-03-03       Impact factor: 2.332

3.  Transient Thresholding: A Mechanism Enabling Noncooperative Transcriptional Circuitry to Form a Switch.

Authors:  Katherine H Aull; Elizabeth J Tanner; Matthew Thomson; Leor S Weinberger
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

4.  Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat.

Authors:  Manabu Taura; Eric Song; Ya-Chi Ho; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-22       Impact factor: 11.205

Review 5.  Understanding HIV latency: the road to an HIV cure.

Authors:  Matthew S Dahabieh; Emilie Battivelli; Eric Verdin
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

Review 6.  Emerging Role of PML Nuclear Bodies in Innate Immune Signaling.

Authors:  Myriam Scherer; Thomas Stamminger
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

Review 7.  Nuclear landscape of HIV-1 infection and integration.

Authors:  Marina Lusic; Robert F Siliciano
Journal:  Nat Rev Microbiol       Date:  2016-12-12       Impact factor: 60.633

Review 8.  Current views on HIV-1 latency, persistence, and cure.

Authors:  Zora Melkova; Prakash Shankaran; Michaela Madlenakova; Josef Bodor
Journal:  Folia Microbiol (Praha)       Date:  2016-10-05       Impact factor: 2.099

9.  TIP60 Complex Inhibits Hepatitis B Virus Transcription.

Authors:  Hironori Nishitsuji; Saneyuki Ujino; Keisuke Harada; Kunitada Shimotohno
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 10.  Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.

Authors:  Moran Benhar; Iart Luca Shytaj; Jonathan S Stamler; Andrea Savarino
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.